国际麻醉学与复苏杂志
國際痳醉學與複囌雜誌
국제마취학여복소잡지
INTERNATIONAL JOURNAL OF ANESTHESIOLOGY AND RESUSCITATION
2012年
2期
84-86,114
,共4页
孙传良%孙朝辉%孙玉兰%李爱荣%黄强
孫傳良%孫朝輝%孫玉蘭%李愛榮%黃彊
손전량%손조휘%손옥란%리애영%황강
右美托咪啶%舒芬太尼%插管法,气管内
右美託咪啶%舒芬太尼%插管法,氣管內
우미탁미정%서분태니%삽관법,기관내
Dexmedetomidine%Sufentanil%Intubation,intratracheal
目的 观察比较不同剂量右美托咪啶(dexmedetomidine,DEX)复合舒芬太尼麻醉诱导用于清醒气管插管的效果.方法 选择Mallampati试验Ⅲ~Ⅳ级患者90例,采用区组随机化法分为3组(每组30例).DEX泵注:Ⅰ组0.8 μg/kg,Ⅱ组1.0 μg/kg,Ⅲ组1.2 μg/kg;均静脉推注舒芬太尼0.1μg/kg.观察并记录入室(T0)、插管前(T1)、插入导管即刻(T2)时的平均动脉压(mean arterial pressure,MAP)、心率(heart rate,HR)、血氧饱和度(oxygen saturation,SpO2)、血浆皮质醇浓度;记录患者插管前镇静(ramsay)评分及插管反应,并术后随访患者. 结果 与T0时(78±10)次/min比较,HR T1时Ⅱ组(68±9)次/min减慢(P<0.05);Ⅲ组T1(68±17)次min、T2时(64±6)次min均减慢(P<0.05).与Ⅰ组(81±12)次/min比较,HR T1时Ⅱ组(68±9)次/min、Ⅲ组(68±17)次/min有所减慢(P<0.05),T2时Ⅲ组(64±6)次/min降低明显(P<0.01).MAPⅡ组T1(102±19) mm Hg(1 mm Hg=0.133 kPa)、T2(109±24) mm Hg时、Ⅲ组T1(104±15) mm Hg、T2(111±9) mm Hg时均有所升高(P<0.05);Ramsay评分,Ⅱ组、Ⅲ 组患者都在4分~5分,结论 DEX 1.0 μg/kg复合0.1 μg/kg舒芬太尼用于清醒气管插管时效果最好,并发症也较少.
目的 觀察比較不同劑量右美託咪啶(dexmedetomidine,DEX)複閤舒芬太尼痳醉誘導用于清醒氣管插管的效果.方法 選擇Mallampati試驗Ⅲ~Ⅳ級患者90例,採用區組隨機化法分為3組(每組30例).DEX泵註:Ⅰ組0.8 μg/kg,Ⅱ組1.0 μg/kg,Ⅲ組1.2 μg/kg;均靜脈推註舒芬太尼0.1μg/kg.觀察併記錄入室(T0)、插管前(T1)、插入導管即刻(T2)時的平均動脈壓(mean arterial pressure,MAP)、心率(heart rate,HR)、血氧飽和度(oxygen saturation,SpO2)、血漿皮質醇濃度;記錄患者插管前鎮靜(ramsay)評分及插管反應,併術後隨訪患者. 結果 與T0時(78±10)次/min比較,HR T1時Ⅱ組(68±9)次/min減慢(P<0.05);Ⅲ組T1(68±17)次min、T2時(64±6)次min均減慢(P<0.05).與Ⅰ組(81±12)次/min比較,HR T1時Ⅱ組(68±9)次/min、Ⅲ組(68±17)次/min有所減慢(P<0.05),T2時Ⅲ組(64±6)次/min降低明顯(P<0.01).MAPⅡ組T1(102±19) mm Hg(1 mm Hg=0.133 kPa)、T2(109±24) mm Hg時、Ⅲ組T1(104±15) mm Hg、T2(111±9) mm Hg時均有所升高(P<0.05);Ramsay評分,Ⅱ組、Ⅲ 組患者都在4分~5分,結論 DEX 1.0 μg/kg複閤0.1 μg/kg舒芬太尼用于清醒氣管插管時效果最好,併髮癥也較少.
목적 관찰비교불동제량우미탁미정(dexmedetomidine,DEX)복합서분태니마취유도용우청성기관삽관적효과.방법 선택Mallampati시험Ⅲ~Ⅳ급환자90례,채용구조수궤화법분위3조(매조30례).DEX빙주:Ⅰ조0.8 μg/kg,Ⅱ조1.0 μg/kg,Ⅲ조1.2 μg/kg;균정맥추주서분태니0.1μg/kg.관찰병기록입실(T0)、삽관전(T1)、삽입도관즉각(T2)시적평균동맥압(mean arterial pressure,MAP)、심솔(heart rate,HR)、혈양포화도(oxygen saturation,SpO2)、혈장피질순농도;기록환자삽관전진정(ramsay)평분급삽관반응,병술후수방환자. 결과 여T0시(78±10)차/min비교,HR T1시Ⅱ조(68±9)차/min감만(P<0.05);Ⅲ조T1(68±17)차min、T2시(64±6)차min균감만(P<0.05).여Ⅰ조(81±12)차/min비교,HR T1시Ⅱ조(68±9)차/min、Ⅲ조(68±17)차/min유소감만(P<0.05),T2시Ⅲ조(64±6)차/min강저명현(P<0.01).MAPⅡ조T1(102±19) mm Hg(1 mm Hg=0.133 kPa)、T2(109±24) mm Hg시、Ⅲ조T1(104±15) mm Hg、T2(111±9) mm Hg시균유소승고(P<0.05);Ramsay평분,Ⅱ조、Ⅲ 조환자도재4분~5분,결론 DEX 1.0 μg/kg복합0.1 μg/kg서분태니용우청성기관삽관시효과최호,병발증야교소.
Objeetive to compare the effect of different dosages of dexmedetomidine (DEX) combined with sufentanil for tracheal intubation in awake patients. Methods Ninety patients with Mallampati test Ⅲ-Ⅳ were randomly assigned into three groups (n=30).Group Ⅰ received intravenously pumping DEX 0.8 μg/kg plus sufentanil 0.1 μg/kg,group Ⅱ with DEX 1.0 μg/kg plus sufentanil 0.1 μg/kg,group Ⅲwith DEX 1.2 μg/kg plus sufentanil 0.1 μg/kg.mean arterial pressure (MAP),heart rate(HR),oxygen saturation (SpO2) of patients were recorded at the time points of entering the operationroom (T0),before intubation (T1) and intubation (T2),respectively.Serial blood samples were obtained for analysis of plasma cortisol concentrations at each time points.The responses at the intubation,and Ramsay scores before intubation were recored.Memory of intubation was inquired after operation. Results HR in patients of group Ⅱ at T1(68±9) beats/min were significantly decreased compared with that at T0(78±10)beats/min (P<0.05),HR inpatients of group Ⅲ at T1 (68±17) beats/min and T2 (64±6) beats/min are significantly decreased compared with that at T0(81±12) beats/min(P<0.05).HR in patients of group Ⅱ (68±9) beats/min and Ⅲ (68±17) beats/min at T1 are significantly decreased compared with that of group Ⅰ (81±12) beats/nin(P~05) and HR in patients of group Ⅲ at T2(64±6) beats/min are significantly decreased compared with that of group Ⅰ (85±15) beats/min(P<0.01).MAP in patients of group Ⅲ at T2(111±-9) mm Hg (1 mm Hg=0.133 kPa) are significantly increased compared with that at T0(98±10) mm Hg(P<0.05 ).MAP in patients of group Ⅱ and Ⅲ at T1 and T2 are significantly increased compared with that of group Ⅰ (P<0.05).Ramsay score in patients of group Ⅱ and Ⅱ at the moment of intubation are significantly higher than that in patients of group Ⅰ (P<0.05). Conclusions These results show that it is optimal for 1.0 μg/kg DEX combined 0.1 μg/kg sufentanil used for awake intubation.